BMJ Group podcasts

Education special: Peripheral nerve disease update

webmaster@bmj.com (BMJ Group) — Tue, 11 Jun 2013 11:06:30 +0000

Ralph Gregory, secretary for the Association of British Neurologists and consultant neurologist in Dorset, gets an update on peripheral nerve disease research and practice from James Overell, consultant neurologist, Institute of Neurological Sciences, Glasgow. They discuss treatment for CIDP,...

Education special: MS update

webmaster@bmj.com (BMJ Group) — Tue, 11 Jun 2013 10:50:06 +0000

Ralph Gregory, secretary for the Association of British Neurologists and consultant neurologist in Dorset, gets an update on multiple sclerosis research and implications for practice from Neil Robertson, professor of neurology, Cardiff University. They discuss new therapeutics BG-12 and...

Stem cells in neurology, and enlarged perivascular spaces and intracerebral haemorrhage

webmaster@bmj.com (BMJ Group) — Tue, 11 Jun 2013 09:54:11 +0000

Where are we with stem cell treatments for stroke and Parkinson’s disease? At the Association of British Neurologists’ recent annual meeting in Glasgow, Neil Scolding, director of the Bristol Institute of Clinical Neurosciences, spoke to Keith Muir, Institute of Neuroscience and Psychology,...

Mark Thompson with great new insights into tendon mechanics and the 2014 International Scientific Tendon symposium in Oxford

webmaster@bmj.com (BMJ Group) — Mon, 3 Jun 2013 11:06:31 +0000

We are talking tendons again in this podcast because the next International Scientific Tendinopathy Symposium has been scheduled for September 5 and 6 in Oxford, UK. This exciting event follows on from two successful conferences in Vancouver in 2012 and Umea in 2010. The consensus paper from the...

June’s ADC podcast

webmaster@bmj.com (BMJ Group) — Thu, 30 May 2013 10:29:58 +0000

In this podcast, Mark Beattie discusses the editor’s highlights from the June edition of ADC. For all the papers discussed, see this month’s edition of the journal http://adc.bmj.com/content/98/6.toc.

June’s Archimedes podcast

webmaster@bmj.com (BMJ Group) — Wed, 29 May 2013 09:34:13 +0000

Archimedes editor Dr Bob Phillips discusses March’s Archimedes questions, including what are the options for treating latent TB infection in children, and can a conservative approach to the treatment of hypertrophic pyloric stenosis with atropine be considered a real alternative to surgical...

Anti-GQ1b antibody syndrome, and ALS and language deficits

webmaster@bmj.com (BMJ Group) — Wed, 22 May 2013 10:18:11 +0000

We know that ALS is associated with executive dysfunction, but what about language deficits? Steven Wing, specialist neurology registrar at Addenbrooke’s Hospital, Cambridge, talks to Laura Goldstein, professor of Clinical Neuropsychology at the Institute of Psychiatry, about her recent paper...

Carl Askling on hamstring injuries - in Swedish

webmaster@bmj.com (BMJ Group) — Mon, 20 May 2013 16:05:17 +0000

Carl Askling, Ph.D., P.T., är forskare och lektor på Gymnastik och Idrottshögskolan, Stockholm och är knuten till Karolinska Institutet, Stockholm. Carl Askling har skrivit en avhandling om akuta skador av hamstringsmuskulaturen, “Hamstring Muscle Strain”, Karolinska Institutet, 2008, och har...

May’s ADC highlights

webmaster@bmj.com (BMJ Group) — Fri, 17 May 2013 13:44:45 +0000

In this podcast, Mark Beattie discusses the editor’s highlights from the May edition of ADC. For all the papers discussed, see this month’s edition of the journal adc.bmj.com/content/98/5.

Striatal cell transplants for Huntington’s disease: where are we now?

webmaster@bmj.com (BMJ Group) — Tue, 14 May 2013 14:12:59 +0000

In Huntington’s disease the striatum takes a big hit early. This has prompted trials of foetal stratal transplantation, in the hope that this may provide some relief to patients. Stevan Wing, specialist neurology registrar at Addenbrooke’s Hospital, and researcher, University of Cambridge, speaks...

What can all nations learn from spanish sports medicine? With a focus on track/field issues and hamstring injuries

webmaster@bmj.com (BMJ Group) — Mon, 13 May 2013 15:29:46 +0000

Dr Juan Manual Alonso is a spanish sports physician and PhD with vast experience in track and field - six Summer Olympic Games just to start! He is the head of the IAAF (Athletics) where he had a global responsibility for antidoping (since 2003) and for guiding athlete care for all 200 countries in...

Qué pueden aprender otros países de la Medicina del Deporte en España – con atención especial a temas de Atletismo y las lesiones de isquiotibiales

webmaster@bmj.com (BMJ Group) — Mon, 13 May 2013 15:18:47 +0000

El Dr Juan Manuel Alonso es un médico del deporte español con dilatada experiencia en el atletismo (¡ha estado presente en 6 juegos olímpicos!). Es el presidente de la Comisión Médica y Anti-dopaje de la IAAF donde se ocupa de la lucha antidopaje y del cuidado general de los atletas de los 200...

Jiri Dvorak on sudden cardiac death, and the Football for Health and 11+ programs

webmaster@bmj.com (BMJ Group) — Mon, 13 May 2013 12:48:31 +0000

Professor Jiri Dvorak discusses the major public health initiative ‘Football for Health’ which has already been adopted in 19 countries. He also introduces that 11 steps to prevent cardiac death and revisits progess on the 11+, a warmup program that reduces lower limb injuries in football....

Exercising at altitude with David Bishop: Does it help team sports?

webmaster@bmj.com (BMJ Group) — Wed, 8 May 2013 10:54:34 +0000

Professor David Bishop, from the Institute of Sport, Exercise, and Active Living (SEAL) at the University of Victoria in Melbourne, Australia, discusses the evidence base for altitude training to improve performance. The innovation is the role in team sports like football codes. He discusses...

Evert Verhagen makes social media and apps intelligible

webmaster@bmj.com (BMJ Group) — Tue, 7 May 2013 11:10:00 +0000

Terrified of Twitter? Afraid of apps? Evert Verhagen, sports scientist and academic from de Vue University Medical Centre, Amsterdam, guides us through everything sports clinicians need to know about social media and apps, and how they can aid clinical practice and health promotion. As well as...

Heart podcast: April 2013

webmaster@bmj.com (BMJ Group) — Wed, 1 May 2013 16:20:39 +0000

In this month’s Heart podcast, Alistair Lindsay talks to Professor Simon Stewart, from the National Health and Medical Research Council of Australia’s Centre of Research Excellence to Reduce Inequality in Heart Disease/Preventative Health. They discuss chronic atrial fibrillation and how it impacts...

Dr Paul McCrory on what athletes need to know about concussion

webmaster@bmj.com (BMJ Group) — Tue, 30 Apr 2013 16:16:39 +0000

Paul McCrory, neurologist and sports physician at the University of Melbourne, talks us through what to do if you think you’ve had a concussion, when you can go back to sport, and what the complications of concussion are.

Dr Paul McCrory explains what parents need to know about concussion

webmaster@bmj.com (BMJ Group) — Tue, 30 Apr 2013 16:14:55 +0000

If you’re worried that your child has had concussion, this podcast is for you. Paul McCrory, neurologist and sports physician at the University of Melbourne, discusses the Concussion Recognition Tool, the guide that you can use if you suspect a diagnosis of concussion. What should you do? Dr...

Dr Paul McCrory’s 3-minute snapshot of what’s new in managing concussion

webmaster@bmj.com (BMJ Group) — Tue, 30 Apr 2013 16:09:36 +0000

Paul McCrory, neurologist and sports physician at the University of Melbourne, gives us the new, take home messages from the latest concussion consensus statement. For a guide to all the content in the latest injury prevention and health protection issue of BJSM, where the consensus is published,...

April’s ADC highlights

webmaster@bmj.com (BMJ Group) — Tue, 23 Apr 2013 11:37:30 +0000

In this podcast, Mark Beattie discusses the editor’s highlights from the April edition of ADC. For all the papers discussed, see this month’s edition of the journal.

Parkinson’s disease subtypes: lost in translation?

webmaster@bmj.com (BMJ Group) — Wed, 17 Apr 2013 16:03:22 +0000

This month Connie Marras, assistant professor of neurology, University of Toronto, talks us through her review of Parkinson’s disease subtypes. What definitions do we have so far, what could they tell us about the condition, and how can we get them incorporated into research more? See...

March’s Archimedes podcast

webmaster@bmj.com (BMJ Group) — Tue, 16 Apr 2013 16:16:51 +0000

Archimedes editor Dr Bob Phillips discusses March’s Archimedes questions, which include if atropine is an effective therapy for pyloric stenosis, and how long to treat patients with latent TB, and with what?

mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway: implications for Crohn’s disease

webmaster@bmj.com (BMJ Group) — Fri, 5 Apr 2013 16:34:27 +0000

Mairi McLean talks to Philip Rosenstiel, Institute of Clinical Molecular Biology, Christian-Albrechts University, Kiel, and Stefan Schreiber, University Hospital Schleswig-Holstein, Kiel, about their paper: mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway:...

Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn’s disease following treatment with certolizumab pegol

webmaster@bmj.com (BMJ Group) — Fri, 5 Apr 2013 16:33:40 +0000

Mairi McLean, Gut’s education editor, talks to Xavier Hébuterne, Department of Gastroenterology and Nutrition, Archet Hospital, Nice, and Jean-Frédéric Colombel, Universite Lille Nord de France, about their paper: Endoscopic improvement of mucosal lesions in patients with moderate to severe...

The SJT fiasco

webmaster@bmj.com (BMJ Group) — Wed, 20 Mar 2013 17:26:23 +0000

Thousands of medical students sat the situational judgement test earlier this year, their results critical to which deanery they would end up in. However an error with the marking meant that some of them had their resulting allocations withdrawn, and were left in limbo whilst their papers were...

The latest on stroke

webmaster@bmj.com (BMJ Group) — Wed, 20 Mar 2013 16:05:04 +0000

In this special edition of the podcast, JNNP associate editor Nick Ward looks into some of the latest research into stroke. Tracking cognitive function in those recovering from stroke in routine. Owen White, associate professor, Department of Neurology, Royal Melbourne Hospital, describes how...

March’s ADC highlights

webmaster@bmj.com (BMJ Group) — Tue, 12 Mar 2013 17:38:46 +0000

Welcome to this first in a new series of ADC podcasts, where editor Mark Beattie takes you through the highlights from the latest issue. This edition covers the March journal, for all the papers discussed see adc.bmj.com.

Dopamine agonist withdrawal syndrome

webmaster@bmj.com (BMJ Group) — Wed, 27 Feb 2013 16:41:33 +0000

The problem of those with Parkinson’s disease becoming addicted to dopamine replacement therapy is well know, but it’s also now emerging that some patients have trouble coming of dopamine agonists. Margarita Pondal, from the Movement Disorders Centre, University of Toronto, talks us through her...

TB special: The ins and outs of interferon-gamma release assays

webmaster@bmj.com (BMJ Group) — Wed, 20 Feb 2013 11:04:32 +0000

We are delighted to present a podcast recording of an interview with Professor Ajit Lalvani to coincide with the TB special edition of Thorax in March. He describes the development of the FDA-approved, NICE and CDC-endorsed interferon-gamma release assay (IGRA, ELISpot, T-SPOT.TB) which he invented...

Non disclosure of HIV status in the clinic

webmaster@bmj.com (BMJ Group) — Tue, 19 Feb 2013 16:48:22 +0000

In the UK, it is estimated that 24% of HIV positive patients are unaware of their infection. This figure is derived from statistical modelling, but how often do people who are identified as having been unaware of their infection are actually just non-disclosing instead? In this podcast Gary Brooks...

BNPA 2013: Stress and war, and the limits of neuropsychiatry

webmaster@bmj.com (BMJ Group) — Mon, 18 Feb 2013 14:13:40 +0000

Neil Greenberg, academic psychiatrist, Kings College London, who’s served in the armed forces for more than 20 years, argued in his JNNP-sponsored keynote at BNPA that we understand many of the issues in military mental health, and that the neuropsychiatric element is relatively small. Alan...

BNPA 2013: The impact of epilepsy on cognitive function

webmaster@bmj.com (BMJ Group) — Fri, 15 Feb 2013 16:34:01 +0000

Cognitive impairment in those with epilepsy is common. Adam Zeman, professor of cognitive and behavioural neurology, University of Exeter, ask Christoph Helmstaedter, associate professor for clinical neuropsychology, the University Clinic of Epileptology in Bonn, about the association, including...

Revising the classification of acute pancreatitis

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 16:33:39 +0000

Mairi McLean, Gut’s education editor, talks to Peter Banks, Division of Gastroenterology, Hepatology, and Endoscopy, Harvard Medical School, and Michael Sarr, Department of Surgery, Mayo Clinic, Rochester, about their revision of the Atlanta classification of acute pancreatitis. See...

BNPA 2013: Psychedelic drugs, magical thinking and psychosis

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 15:11:26 +0000

Robin Carhart-Harris, post-doctoral researcher, Division of Brain Sciences, Imperial College London, explains his hypothesis on the shared neurobiology of psychosis, psychedelic states and spontaneous spiritual experiences to Peter Halligan, professor in the School of Psychology, Cardiff...

BNPA 2013: Decoding consciousness

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 15:08:52 +0000

What relevance does consciousness have for our understanding of mental conditions? Geraint Rees, deputy head of the UCL Faculty of Brain Sciences, tells Peter Halligan, professor in the School of Psychology, Cardiff University, about his work in the area. This podcast was recorded at the British...

BNPA 2013: Epilepsy, depression and anxiety disorders

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 15:04:59 +0000

There is a complex relationship between epilepsy, depression, and anxiety disorders. Adam Zeman, professor of cognitive and behavioural neurology, University of Exeter, discusses the associations and what they mean for practice with Andres Kanner, director of the Comprehensive Epilepsy Center,...

BNPA 2013: Brain networks in human epilepsy

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 15:03:22 +0000

How epileptic seizures start is unclear. Mark Richardson, professor of epilepsy, Institute of Psychiatry, is working on elucidating this question using computational models. He talks Markus Reuber, professor of clinical neurology, University of Sheffield, through his research. This podcast was...

BNPA 2013: Cellular mechanisms of epilepsy

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 15:00:38 +0000

Markus Reuber, professor of clinical neurology, University of Sheffield, discusses the different cellular mechanisms which allow seizures in epilepsy to happen, and how this understanding could lead to disease modification with John Jefferys, professor of neuroscience, University of...

BNPA 2013: Autoimmunity and neuropsychiatry

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 14:51:12 +0000

Tim Nicholson, academic clinical lecturer, Institute of Psychiatry, gives Hugh Rickards, consultant in neuropsychiatry, University of Birmingham, an update on autoimmune mechanisms and encephalitis. Dr Nicholson covers where we are with understanding and treating paediatric autoimmune...

BNPA 2013: Deep brain stimulation for mental illness

webmaster@bmj.com (BMJ Group) — Tue, 12 Feb 2013 14:49:31 +0000

Eileen Joyce, professor in neuropsychiatry at the Institute of Neurology, gives Hugh Rickards, consultant in neuropsychiatry, University of Birmingham, an update on the use of deep brain stimulation to treat mental disorders, particularly OCD. This podcast was recorded at the British...